Cancer Care in the National Cancer Institute Center for Cancer Research
|First Received Date ICMJE||June 17, 2009|
|Last Updated Date||May 17, 2013|
|Start Date ICMJE||April 2004|
|Primary Completion Date||Not Provided|
|Current Primary Outcome Measures ICMJE||Not Provided|
|Original Primary Outcome Measures ICMJE||Not Provided|
|Change History||Complete list of historical versions of study NCT00923065 on ClinicalTrials.gov Archive Site|
|Current Secondary Outcome Measures ICMJE||Not Provided|
|Original Secondary Outcome Measures ICMJE||Not Provided|
|Current Other Outcome Measures ICMJE||Not Provided|
|Original Other Outcome Measures ICMJE||Not Provided|
|Brief Title ICMJE||Cancer Care in the National Cancer Institute Center for Cancer Research|
|Official Title ICMJE||Care of Adult Oncology Patient, CCR, NCI|
This study provides cancer care through the National Cancer Institute's Medical Oncology Branch (MOB) to patients who are not enrolled in an active treatment research protocol. Patients receive standard treatments only; no investigational therapies are provided on this protocol.
Patients 18 years of age and older may be eligible for this protocol. Candidates are patients for whom an NCI investigator decides that the interests of the patient and the NCI are best served by the patient's enrollment in this protocol to receive care and follow-up within the MOB. This includes patients in the following categories:
Participants receive standard medical care, including periodic routine laboratory tests, diagnostic x-rays, and nuclear medicine scans to monitor the course of illness and the effects of any treatment.
It may be in the interest of the Center for Cancer Research (CCR) to treat and/or follow certain subjects who are not currently enrolled on an active research protocol.
The objective of this protocol is to provide treatment and medical follow-up for NCI patients and other Institute consult patients not currently enrolled on an active research protocol.
It is in the best interests of the subject and the CCR for the subject to receive treatment at the NCI, NIH Intramural Research Program.
No investigational therapies will be administered on this study. This protocol is not a platform to perform pilot studies of off-label uses for standard agents.
This protocol will provide the administrative vehicle to provide cancer care for patients in the intramural research program.
Medical/surgical/radiotherapeutic care, treatment and follow-up is provided for subjects who are not currently enrolled on an active protocol.
|Study Type ICMJE||Observational|
|Study Design ICMJE||Not Provided|
|Target Follow-Up Duration||Not Provided|
|Sampling Method||Not Provided|
|Study Population||Not Provided|
|Intervention ICMJE||Not Provided|
|Study Group/Cohort (s)||Not Provided|
|Publications *||Not Provided|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
|Recruitment Status ICMJE||Recruiting|
|Estimated Enrollment ICMJE||1000|
|Completion Date||Not Provided|
|Primary Completion Date||Not Provided|
|Eligibility Criteria ICMJE||
Patient must be age 18 or older.
A CCR investigator decides that it is in the best interest of the patient and the CCR for the subject to receive treatment and follow-up at the NCI/NIH.
The patient is able and willing to provide informed consent.
Subjects who are receiving an investigational therapy.
|Ages||18 Years and older|
|Accepts Healthy Volunteers||No|
|Location Countries ICMJE||United States|
|NCT Number ICMJE||NCT00923065|
|Other Study ID Numbers ICMJE||040165, 04-C-0165|
|Has Data Monitoring Committee||Not Provided|
|Responsible Party||Not Provided|
|Study Sponsor ICMJE||National Cancer Institute (NCI)|
|Collaborators ICMJE||Not Provided|
|Information Provided By||National Institutes of Health Clinical Center (CC)|
|Verification Date||March 2013|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP